Up to now, only the calpain small subunit 1 (CAPN4) was demonstrated as a marker for poor clinical outcome in NPC patients, and was shown to be significantly correlated with EBV infection. The gene discussed is CAPNS1; the disease is Epstein-Barr virus infection.